Prelude Therapeutics Inc
PRLD- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001678660
No open-market purchases or sales by Prelude Therapeutics Inc insiders were filed in the last 90 days; 75 institutions reported holding it in 13F filings for Q2 2026, worth $264.3M in total; no superinvestor holds it.
13F holders, Q3 2022
Institutional positions in Prelude Therapeutics Inc as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 53
- −8 vs. Q2 2022
- Shares held
- 31.8M
- −913.7K (−2.8%) vs. Q2 2022
- Total value
- $210.3M
- +$39.5M (+23.1%) vs. Q2 2022
- New holders
- 5
- 16 more added
- Sold out
- 13
- 20 more reduced
1 institution that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PRLD on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 75 | $264.3M |
| Q1 2026 | 55 | $105.2M |
| Q4 2025 | 48 | $82.6M |
| Q3 2025 | 47 | $39.1M |
| Q2 2025 | 50 | $22.0M |
| Q1 2025 | 59 | $23.3M |
| Q4 2024 | 62 | $41.0M |
| Q3 2024 | 70 | $74.0M |
| Q2 2024 | 61 | $129.2M |
| Q1 2024 | 58 | $162.1M |
| Q4 2023 | 56 | $148.3M |
| Q3 2023 | 60 | $113.1M |
| Q2 2023 | 55 | $176.2M |
| Q1 2023 | 55 | $179.6M |
| Q4 2022 | 60 | $188.3M |
| Q3 2022 | 53 | $210.3M |
| Q2 2022 | 62 | $170.9M |
| Q1 2022 | 68 | $235.4M |
| Q4 2021 | 75 | $437.6M |
| Q3 2021 | 61 | $1.12B |
| Q2 2021 | 57 | $986.6M |
| Q1 2021 | 60 | $1.41B |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Prelude Therapeutics Inc; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| UBS Group AG | 68 | $0 | 0.00% | −2,638−97.5% | Reduced |
| Capital Advisors, Ltd. LLC | 33 | $0 | 0.00% | +22+200.0% | Added |
| HighMark Wealth Management LLC | 50 | $0 | 0.00% | 00.0% | Unchanged |
| Daiwa Securities Group Inc. | 104 | $1.00K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 371 | $2.00K | 0.00% | +184+98.4% | Added |
| Advisor Group Holdings, Inc. | 500 | $3.00K | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 470 | $3.00K | 0.00% | +470 | New |
| China Universal Asset Management Co., Ltd. | 448 | $3.00K | 0.00% | +448 | New |
| Tower Research Capital LLC (TRC) | 1,254 | $9.00K | 0.00% | −2,770−68.8% | Reduced |
| Quantbot Technologies LP | 1,400 | $9.00K | 0.00% | −1,400−50.0% | Reduced |
| Federated Hermes, Inc. | 1,407 | $9.00K | 0.00% | +1,141+428.9% | Added |
| JPMorgan Chase & Co | 2,451 | $16.0K | 0.00% | +418+20.6% | Added |
| Nisa Investment Advisors, LLC | 4,000 | $27.0K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 4,200 | $28.0K | 0.00% | +1,699+67.9% | Added |
| Barclays PLC | 5,168 | $34.0K | 0.00% | +1,108+27.3% | Added |
| Denali Advisors LLC | 8,200 | $54.0K | 0.03% | +8,200 | New |
| Citigroup Inc | 8,532 | $56.0K | 0.00% | +7,691+914.5% | Added |
| PDT Partners, LLC | 12,641 | $84.0K | 0.01% | −31,090−71.1% | Reduced |
| Susquehanna International Group, LLP | 13,591 | $90.0K | 0.00% | −15,837−53.8% | Reduced |
| Dimensional Fund Advisors LP | 14,616 | $97.0K | 0.00% | +14,616 | New |
| Citadel Advisors LLC | 15,734 | $104.0K | 0.00% | −93,889−85.6% | Reduced |
| Commonwealth Equity Services, LLC | 15,867 | $104.0K | 0.00% | −750−4.5% | Reduced |
| Northern Trust Corp | 21,167 | $140.0K | 0.00% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 21,735 | $144.0K | 0.00% | −22,560−50.9% | Reduced |
| Virtus ETF Advisers LLC | 24,180 | $160.0K | 0.06% | +175+0.7% | Added |
| TD Asset Management Inc | 28,440 | $185.0K | 0.00% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 29,179 | $193.0K | 0.00% | −100.0% | Reduced |
| Manufacturers Life Insurance Company, The | 34,267 | $223.5K | 0.00% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 36,949 | $244.0K | 0.01% | −10,000−21.3% | Reduced |
| State Street Corp | 43,889 | $290.0K | 0.00% | 00.0% | Unchanged |
| Charles Schwab Investment Management Inc | 54,052 | $358.0K | 0.00% | −9,148−14.5% | Reduced |
| Gsa Capital Partners LLP | 54,173 | $358.0K | 0.05% | +17,547+47.9% | Added |
| Millennium Management LLC | 60,426 | $399.0K | 0.00% | −30,511−33.6% | Reduced |
| New York Life Investment Management LLC | 73,393 | $485.0K | 0.01% | +5,808+8.6% | Added |
| D. E. Shaw & Co., Inc. | 78,881 | $521.0K | 0.00% | −36,986−31.9% | Reduced |
| Caxton Associates LP | 85,992 | $568.0K | 0.10% | +2,125+2.5% | Added |
| Two Sigma Investments, LP | 105,601 | $698.0K | 0.00% | −118,235−52.8% | Reduced |
| State of Wisconsin Investment Board | 109,100 | $721.0K | 0.00% | −18,100−14.2% | Reduced |
| Two Sigma Advisers, LP | 109,533 | $724.0K | 0.00% | −126,167−53.5% | Reduced |
| Candriam Luxembourg S.C.A. | 125,619 | $830.0K | 0.01% | +125,619 | New |
| Renaissance Technologies LLC | 143,400 | $948.0K | 0.00% | −17,086−10.6% | Reduced |
| Geode Capital Management, LLC | 153,091 | $1.01M | 0.00% | +17,450+12.9% | Added |
| Bank of America Corp | 167,478 | $1.11M | 0.00% | +33,983+25.5% | Added |
| Morgan Stanley | 177,788 | $1.18M | 0.00% | −303,000−63.0% | Reduced |
| Price T Rowe Associates Inc | 313,165 | $2.07M | 0.00% | +5,812+1.9% | Added |
| BlackRock Inc. | 459,134 | $3.03M | 0.00% | −70,301−13.3% | Reduced |
| Massachusetts Financial Services Co | 513,293 | $3.39M | 0.00% | +34,768+7.3% | Added |
| HHLR Advisors, Ltd.SuperinvestorHHLR Advisors (Hillhouse) | 583,333 | $3.86M | 0.10% | 00.0% | Unchanged |
| Vanguard Group Inc | 899,045 | $5.94M | 0.00% | 00.0% | Unchanged |
| UBS Asset Management Americas Inc | 2,402,595 | $15.9M | 0.01% | −17,932−0.7% | Reduced |
| FMR LLC | 4,638,547 | $30.7M | 0.00% | +335,578+7.8% | Added |
| OrbiMed Advisors LLC | 10,039,691 | $66.4M | 1.32% | 00.0% | Unchanged |
| Baker Bros. Advisors LP | 10,123,824 | $66.9M | 0.44% | 00.0% | Unchanged |
| Rock Springs Capital Management LP | 0 | $0 | 0.00% | −368,959−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −45,716−100.0% | Sold out |
| Ergoteles LLC | 0 | $0 | 0.00% | −43,500−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −39,938−100.0% | Sold out |
| Occudo Quantitative Strategies LP | 0 | $0 | 0.00% | −23,640−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −19,618−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −18,000−100.0% | Sold out |
| Delphia (USA) Inc. | 0 | $0 | 0.00% | −16,940−100.0% | Sold out |
| Corton Capital Inc. | 0 | $0 | 0.00% | −15,586−100.0% | Sold out |
| Ensign Peak Advisors, Inc | 0 | $0 | 0.00% | −8,080−100.0% | Sold out |
| New York State Common Retirement Fund | 0 | $0 | 0.00% | −92−100.0% | Sold out |
| Credit Suisse AG | 0 | $0 | 0.00% | −6−100.0% | Sold out |
| Cutler Group LP | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Brewin Dolphin Wealth Management Ltd | – | – | – | – | Not filed |